Steve Schneider

Steve Schneider is a seasoned professional in the field of commercial analytics and sales operations, currently serving as the Director of Field Analytics & Operations at BridgeBio since March 2024. Previously, Steve held the position of Associate Director of Commercial Analytics at Rigel Pharmaceuticals Inc. from December 2017 to March 2024, where responsibilities included incentive compensation development, sales force sizing, and competitive data analysis. Other notable roles include Senior Manager of Sales and Field Operations at Puma Biotechnology, as well as various sales operations and forecasting roles for companies like Onyx Pharmaceuticals and as a consultant. Steve’s career began as a Financial Analyst at Quadramed Corporation and Leap Frog, complemented by a BA from the University of Colorado Boulder and an MBA from San Francisco State University.